Total Payments
$2,798
2024 Payments
$49.76
Companies
27
Transactions
138
Medicare Patients
698
Medicare Billing
$43,191
Payment Breakdown by Category
Food & Beverage$2,798 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,798 | 138 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $454.73 | 16 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $326.70 | 21 | $0 (2022) |
| Novo Nordisk Inc | $299.99 | 19 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $293.62 | 14 | $0 (2022) |
| Merck Sharp & Dohme LLC | $210.28 | 12 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $196.86 | 7 | $0 (2022) |
| GlaxoSmithKline, LLC. | $129.50 | 4 | $0 (2023) |
| Lilly USA, LLC | $122.69 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $84.57 | 4 | $0 (2022) |
| Celgene Corporation | $78.28 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49.76 | 2 | Lilly USA, LLC ($26.08) |
| 2023 | $656.36 | 27 | ABBVIE INC. ($240.57) |
| 2022 | $1,010 | 50 | ABBVIE INC. ($214.16) |
| 2021 | $1,082 | 59 | Novo Nordisk Inc ($258.57) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Lilly USA, LLC | OMVOH (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: LIVER DISEASE | ||||||
| 10/21/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $83.48 | General |
| Category: RESPIRATORY | ||||||
| 08/25/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.23 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.23 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.29 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/09/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: Urology | ||||||
| 05/25/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/22/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Urology | ||||||
| 05/18/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/02/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/01/2023 | Medtronic, Inc. | NURO (Device) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Tibial Nerve Stimulation | ||||||
| 04/28/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.01 | General |
| Category: Neuroscience | ||||||
| 04/27/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/30/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: IMMUNOLOGY | ||||||
| 03/23/2023 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: GI COLON PREP | ||||||
| 03/10/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.65 | General |
| Category: Neuroscience | ||||||
| 03/03/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/02/2023 | ABBVIE INC. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: IMMUNOLOGY | ||||||
| 03/01/2023 | Hologic Sales and Service, LLC | CoolSeal Generator (Device) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Surgical | ||||||
| 02/10/2023 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/09/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.29 | General |
| Category: Neuroscience | ||||||
| 02/02/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 512 | 566 | $113,824 | $30,341 |
| 2022 | 2 | 186 | 204 | $34,894 | $12,850 |
Total Patients
698
Total Services
770
Medicare Billing
$43,191
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 188 | 226 | $33,864 | $11,378 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 94 | $35,068 | $7,124 | 20.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 97 | 97 | $20,952 | $4,979 | 23.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 40 | 40 | $15,400 | $4,275 | 27.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 13 | 13 | $2,728 | $935.09 | 34.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 42 | 42 | $2,310 | $631.68 | 27.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 40 | 40 | $2,200 | $594.17 | 27.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $1,302 | $423.36 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 131 | $19,126 | $7,815 | 40.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 73 | 73 | $15,768 | $5,035 | 31.9% |
About German Restrepo, ANP
German Restrepo, ANP is a Registered Nurse healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2010. The National Provider Identifier (NPI) number assigned to this provider is 1023332848.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, German Restrepo, ANP has received a total of $2,798 in payments from pharmaceutical and medical device companies, with $49.76 received in 2024. These payments were reported across 138 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,798).
As a Medicare-enrolled provider, Restrepo has provided services to 698 Medicare beneficiaries, totaling 770 services with total Medicare billing of $43,191. Data is available for 2 years (2022–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Adult Health, Adult Health
- Location Orlando, FL
- Active Since 03/23/2010
- Last Updated 07/10/2023
- Taxonomy Code 163W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023332848
Products in Payments
- FARXIGA (Drug) $272.84
- UBRELVY (Drug) $254.98
- TRADJENTA (Drug) $226.48
- Ozempic (Drug) $189.27
- DIFICID (Drug) $137.77
- SOLIQUA 100/33 (Biological) $96.86
- AREXVY (Drug) $83.48
- ZEPOSIA (Drug) $78.28
- TRULICITY (Drug) $76.48
- SPIRIVA RESPIMAT (Drug) $67.14
- RYBELSUS (Drug) $57.45
- ELIQUIS (Drug) $56.14
- GARDASIL 9 (Biological) $55.51
- BREZTRI (Drug) $53.86
- SKYRIZI (Biological) $53.75
- Livalo (Drug) $53.53
- Axonics (Device) $52.03
- Kerendia (Drug) $48.61
- LINZESS (Drug) $47.67
- XARELTO (Drug) $41.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Orlando
Boni May, Aprn, APRN
Registered Nurse — Payments: $13,671
Registered Nurse $13,671
April Mieswinkel, Fnp, FNP
Registered Nurse — Payments: $4,549
Registered Nurse $4,549
Nicole Bonilla Jimenez, Msn, MSN
Registered Nurse — Payments: $4,194
Registered Nurse $4,194
Mrs. Amanda Crane, Arnp, ARNP
Registered Nurse — Payments: $3,533
Registered Nurse $3,533
Tiffany Graves, Aprn, APRN
Registered Nurse — Payments: $3,329
Registered Nurse $3,329
Kevin Hendrickson, Np, NP
Registered Nurse — Payments: $3,056
Registered Nurse $3,056